Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis
-
Published:2024-07
Issue:7
Volume:28
Page:1194-1205
-
ISSN:1091-255X
-
Container-title:Journal of Gastrointestinal Surgery
-
language:en
-
Short-container-title:Journal of Gastrointestinal Surgery
Author:
Sabra Hamdy Khaled,
Remeih Gehad S.,
Kereet Ibraheem M.,
Hamad Mohammad,
Ahmed Yassmien Ali,
Jahangir Kainat,
Bakr Mostafa Abdulraheem,
Alagelli Fatma Assad,
Sherif Hadeer,
Elsaid MohamedORCID
Reference67 articles.
1. Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial;Eliasson;J Parent Enter Nutr,2022
2. Medical update and potential advances in the treatment of pediatric intestinal failure;Youssef;Curr Gastroenterol Rep,2012
3. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults;Pironi;Clin Nutr,2015
4. Short bowel syndrome: highlights of patient management, quality of life, and survival;Kelly;J Parent Enter Nutr,2014
5. Quality of life and concerns in patients with short bowel syndrome;Carlsson;Clin Nutr,2003
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献